这类药物包括贝那普利(洛汀新)、卡托普利(开博通)、依那普利等。
Medications in this category include benazepril (Lotensin), captopril (Capoten) and enalapril (Vasotec).
目的观察尿毒清颗粒联合洛汀新治疗肾性高血压的疗效和安全性。
Objective To observe the therapeutic effect and safety of niaoduqing particles combined with lotensin on renal hypertension (RH).
结论尿毒清颗粒联合洛汀新治疗肾性高血压安全有效，其疗效优于单独使用洛汀新。
Conclusion Nniaoduqing particles combined with lotensin was efficient and safe for the treatment of RH, which was more efficient than lotensin alone.
方法：分别测定高血压病组和正常对照组crp的浓度水平，洛汀新口服12周后两组的血浆CRP浓度变化。
Method: Determination of essential hypertension group and normal control group the concentration of CRP level lotensin oral group after 12 weeks of the change in plasma CRP concentration.
方法：分别测定高血压病组和正常对照组crp的浓度水平，洛汀新口服12周后两组的血浆CRP浓度变化。
Method: Determination of essential hypertension group and normal control group the concentration of CRP level lotensin oral group after 12 weeks of the change in plasma CRP concentration.
应用推荐